Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 32 resultados

STRIM: Scientific Training for Post Translational Modification Detection in Cancer Screening Cancer remains one of the greatest challenges to the EU healthcare systems. Early detection and diagnosis dramatically increases the prospec...
2024-06-28 - 2028-09-30 | Financiado

META-CYCLE: New players in the regulation of DNA replication fork speed KRAEFTENS BEKAEMPELSE tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Faithful eucaryotic cell division requires spatio-temporal orchestration of multiple sequential events. Among the crucial steps to providing...
2023-05-08 - 2025-12-31 | Financiado

DECIDER: Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance... KRAEFTENS BEKAEMPELSE participó en un H2020: H2020-SC1-BHC-2018-2020 The goals of this inter-disciplinary project are to 1) gain understanding of the mechanisms causing chemoresistance in high-grade serous ova...
2021-01-21 - 2026-07-31 | Financiado

RadoNorm: Towards effective radiation protection based on improved scientific evidence and social consideratio... KRAEFTENS BEKAEMPELSE participó en un H2020: NFRP-2019-2020 RadoNorm is designed to initiate and perform research and technical development in support of European Union Member States, Associated Count...
2020-05-18 - 2025-08-31 | Financiado

REMEDIA: Impact of exposome on the course of lung diseases KRAEFTENS BEKAEMPELSE participó en un H2020: H2020-SC1-BHC-2018-2020 Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are two very debilitating non-communicable diseases that are of partic...
2019-12-06 - 2024-12-31 | Financiado

PanCareFollowUp: PanCareFollowUp Novel patient centred survivorship care to improve care quality effectiveness co... KRAEFTENS BEKAEMPELSE participó en un H2020: H2020-SC1-BHC-2018-2020 The 5-year survival for children with cancer increased from 30% in the 1970s to more than 80% at present. There are up to 300,000 childhood...
2018-12-10 - 2023-12-31 | Financiado

rDNAstress: Novel insights into DNA damage and stress responses in the nucleolus Mechanisms and relevance for g... KRAEFTENS BEKAEMPELSE tramitó un H2020: H2020-MSCA-IF-2017 Incidence of grave pathologies including neurodegeneration and cancer increases in today’s aging European populations and new approaches to...
2018-04-17 - 2020-12-31 | Financiado

SYNTRAIN: Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network KRAEFTENS BEKAEMPELSE participó en un H2020: H2020-MSCA-ITN-2016 Breast and ovarian cancer constitute serious health challenges in the EU. To identify new improved cancer therapeutic approaches, we will pu...
2016-08-10 - 2020-11-30 | Financiado

MEL-PLEX: Exploiting MELanoma disease comPLEXity to address European research training needs in translational... KRAEFTENS BEKAEMPELSE participó en un H2020: H2020-MSCA-ITN-2014 Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous a...
2014-12-16 - 2018-11-30 | Financiado

SYNvia: Exploring synthetic lethality and synthetic viability to elucidate responses of breast and prost... KRAEFTENS BEKAEMPELSE tramitó un FP7: The key objective of this Marie Curie project is to explore the ‘synthetic lethality’ and ‘synthetic viability’ principles applied to DNA da...
Financiado

QUIET: Health consequences of noise exposure from road traffic KRAEFTENS BEKAEMPELSE tramitó un FP7: There is growing public concern about adverse effects of traffic noise on health, as research has found that traffic noise increases the ris...
Financiado

LYSOSOME: Lysosomes as targets for cancer therapy KRAEFTENS BEKAEMPELSE tramitó un FP7: Knowing that the lysosomes contain a powerful cocktail of hydrolases capable of digesting cells and entire tissues, it is obvious that the m...
Financiado

APO-SYS: Apoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology... KRAEFTENS BEKAEMPELSE participó en un FP7: A Europe-wide consortium of experimental biologists, biomathematicians, biostatisticians, computer scientists and clinical scientists will t...
Financiado

GENICA: Genomic Instability in Cancer and Precancer KRAEFTENS BEKAEMPELSE participó en un FP7: Genomic instability is a characteristic of practically all human cancers. Recent results generated by members of this Consortium suggest tha...
Financiado

ESCAPE: European Study of Cohorts for Air Pollution Effects KRAEFTENS BEKAEMPELSE participó en un FP7: European policy making is hampered by considerable uncertainty about the magnitude and nature of the impacts of long term exposure to air po...
Financiado

CHANCES: Consortium on Health and Ageing Network of Cohorts in Europe and the United States KRAEFTENS BEKAEMPELSE participó en un FP7: CHANCES aims at combining and integrating on-going cohort studies in order to produce evidence on ageing-related health characteristics and...
Financiado

EUROCANPLATFORM: A European Platform for Translational Cancer Research KRAEFTENS BEKAEMPELSE participó en un FP7: Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the i...
Financiado

EUROCOURSE: Europe against Cancer Optimisation of the Use of Registries for Scientific Excellence in research EUROCOURSE will tackle fragmentation in the funding and usage of cancer registries in Europe. It will do so by exploring ways to link and in...
Financiado

DCS